Cargando…

FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice

Fibroblast growth factor receptor 1 (FGFR1) is frequently amplified in human small-cell lung cancer (SCLC), but its contribution to SCLC and other lung tumors has remained elusive. Here, we assess the tumorigenic capacity of constitutive-active FGFR1 (FGFR1(K656E)) with concomitant RB and P53 deplet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferone, Giustina, Song, Ji-Ying, Krijgsman, Oscar, van der Vliet, Jan, Cozijnsen, Miranda, Semenova, Ekaterina A., Adams, David J., Peeper, Daniel, Berns, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090386/ https://www.ncbi.nlm.nih.gov/pubmed/32187553 http://dx.doi.org/10.1016/j.celrep.2020.02.052

Ejemplares similares

Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer
por: Böttger, Franziska, et al.
Publicado: (2019)

Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice
por: Badhai, Jitendra, et al.
Publicado: (2020)

Drugging the addict: non‐oncogene addiction as a target for cancer therapy
por: Nagel, Remco, et al.
Publicado: (2016)

Cells of origin of lung cancers: lessons from mouse studies
por: Ferone, Giustina, et al.
Publicado: (2020)

SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
por: Ferone, Giustina, et al.
Publicado: (2016)

Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
por: Semenova, Ekaterina A., et al.
Publicado: (2016)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
por: Haferkamp, Sebastian, et al.
Publicado: (2009)

Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer
por: Mandigo, Amy C., et al.
Publicado: (2022)

FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
por: Ying, Xihui, et al.
Publicado: (2019)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
por: Hong, Chen, et al.
Publicado: (2022)

Origins, genetic landscape, and emerging therapies of small cell lung cancer
por: Semenova, Ekaterina A., et al.
Publicado: (2015)

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
por: Furugaki, Koh, et al.
Publicado: (2023)

Sonic Hedgehog in SCLC
por: Laukkanen, Mikko O., et al.
Publicado: (2015)

Pathology and Classification of SCLC
por: Raso, Maria Gabriela, et al.
Publicado: (2021)

RB1CC1 Together with RB1 and p53 Predicts Long-Term Survival in Japanese Breast Cancer Patients
por: Chano, Tokuhiro, et al.
Publicado: (2010)

Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis
por: Kwon, Min-chul, et al.
Publicado: (2015)

Oncogenic FGFR3 gene fusions in bladder cancer
por: Williams, Sarah V., et al.
Publicado: (2013)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

What Are the Biomarkers for Immunotherapy in SCLC?
por: Longo, Vito, et al.
Publicado: (2021)

Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021)

Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors
por: Li, Fangda, et al.
Publicado: (2020)

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer
por: Malchers, Florian, et al.
Publicado: (2023)

p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?
por: Poller, D. N., et al.
Publicado: (1997)

Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution
por: Kumar, Prashant, et al.
Publicado: (2012)

A Pan-Cancer Assessment of RB1/TP53 Co-Mutations
por: Cai, Ling, et al.
Publicado: (2022)

Cdk6: At the interface of Rb and p53
por: Nebenfuehr, Sofie, et al.
Publicado: (2018)

FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma
por: Zhou, Haiping, et al.
Publicado: (2016)

Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma
por: Tasaka, Keiji, et al.
Publicado: (2022)

What's New in SCLC? A Review
por: Oronsky, Bryan, et al.
Publicado: (2017)

The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription Factor FOXQ1 to Promote Breast Cancer Cell Growth
por: Lin, Yan, et al.
Publicado: (2023)

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance: Understanding SCLC heterogeneity and plasticity in metastasis and chemoresistance
por: Jin, Yujuan, et al.
Publicado: (2023)

Study of polymorphisms in the TP53 and RB1 genes in children with retinoblastoma in northern Mexico
por: Anaya-Pava, Edwin J., et al.
Publicado: (2017)

p53 and RB1 regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis
por: Cain, Jason E., et al.
Publicado: (2020)

Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma
por: Saghaeiannejad Esfahani, Hoda, et al.
Publicado: (2021)

FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium
por: Best, Sarah A., et al.
Publicado: (2018)

The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
por: Santolla, Maria Francesca, et al.
Publicado: (2020)

Identification of a novel oncogenic mutation of FGFR4 in gastric cancer
por: Futami, Takashi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eh9073lv79ai9fuv6t2l8dorjt